RaeSedo
About:
RaeSedo generates and optimizes new and improved structural peptidomimetics for the treatment of asthma.
Website: https://raesedoinc.com
Top Investors: NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
Description:
RaeSedo generates and optimizes new and improved structural peptidomimetics for the treatment of asthma. Drs. Monica Kraft and Julie Ledford received SSTR funding for a Phase I proposal to develop new, short peptide derivatives and mimetics of the active.
Total Funding Amount:
$3.45M
Headquarters Location:
Arizona City, Arizona, United States
Founded Date:
2019-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2022-11-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai